ACCENTIA BIOPHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$8.5M

152 transactions

Summary

ACCENTIA BIOPHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $8.1MSales: $100K18 insiders

Date	Insider	Type	Value
2011-12-23	ODONNELL FRANCIS E JR(Executive Chairman)	Sell	$100K
2012-04-12	ODONNELL FRANCIS E JR(EXECUTIVE CHAIRMAN)	J	$37K
2013-11-08	ODONNELL FRANCIS E JR	J	$14K
2012-10-24	ODONNELL FRANCIS E JR(EXECUTIVE CHAIRMAN)	J	$0
2012-08-24	DUFFEY SAMUEL S(CEO/PRESIDENT/GENERAL COUNSEL)	A	$0
2012-08-24	Santos Carlos(Sr. VP of Prod Dev/Reg Affairs)	A	$0
2012-08-24	Calder Douglas W(VP Strategic Plan/Cap Markets)	A	$0
2012-08-24	Hasara Garrison J.(Acting Chief Financial Officer)	A	$0
2012-02-29	ODONNELL FRANCIS E JR(EXECUTIVE CHAIRMAN)	A	$0
2012-02-29	DUFFEY SAMUEL S(CEO/PRESIDENT/GENERAL COUNSEL)	A	$0
2012-02-29	Hasara Garrison J.(Acting Chief Financial Officer)	A	$0
2012-02-29	Poole William	A	$0
2012-02-29	SCHUBERT DAVID M	A	$0
2012-02-29	CHAPMAN CHRISTOPHER C	A	$0
2012-02-29	KING EDMUND	A	$0
2012-02-29	Calder Douglas W(VP Strategic Plan/Cap Markets)	A	$0
2012-02-29	Santos Carlos(Chief Science Officer)	A	$0
2012-02-17	ODONNELL FRANCIS E JR(EXECUTIVE CHAIRMAN)	J	$0
2012-02-17	ODONNELL FRANCIS E JR(EXECUTIVE CHAIRMAN)	J	$0
2011-10-05	ODONNELL FRANCIS E JR(CHAIRMAN & CEO)	J	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ACCENTIA BIOPHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope